(Q40309654)

19 September 2017

title

Gene therapy of ovarian cancer with IFN-alpha-producing fibroblasts: comparison of constitutive and inducible vectors (English)

1 reference

19 September 2017

0 references

1 reference

1

1 reference

19 September 2017

2

1 reference

19 September 2017

Tisato V

3

1 reference

19 September 2017

Gola E

4

1 reference

19 September 2017

Minuzzo S

5

1 reference

19 September 2017

Roni V

6

1 reference

19 September 2017

Persano L

7

1 reference

19 September 2017

Chieco-Bianchi L

8

1 reference

19 September 2017

Amadori A

9

1 reference

19 September 2017

publication date

2 March 2006

1 reference

19 September 2017

1 reference

19 September 2017

volume

13

1 reference

19 September 2017

issue

12

1 reference

19 September 2017

page(s)

953-965

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.gt.3302745

19 September 2017

exact match

0 references

cites work

Estimates of the worldwide mortality from 25 cancers in 1990.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302745

Gene therapy for ovarian cancer: progress and potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302745

Why did p53 gene therapy fail in ovarian cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302745

Antitumoral effect of interleukin-12-secreting fibroblasts in a mouse model of ovarian cancer: implications for the use of ovarian cancer biopsy-derived fibroblasts as a vehicle for regional gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302745

Inhibition of angiogenesis and vascular tumor growth by interferon-producing cells: A gene therapy approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302745

Differential effects of angiostatin, endostatin and interferon-alpha(1) gene transfer on in vivo growth of human breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302745

Antiangiogenic therapy against experimental glioblastoma using genetically engineered cells producing interferon-alpha, angiostatin, or endostatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302745

Interferon-alpha gene therapy for cancer: retroviral transduction of fibroblasts and particle-mediated transfection of tumor cells are both effective strategies for gene delivery in murine tumor models

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302745

IL-12 gene therapy using direct injection of tumors with genetically engineered autologous fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302745

Gene therapy of cancer: a pilot study of IL-4-gene-modified fibroblasts admixed with autologous tumor to elicit an immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302745

Interferon-alpha in tumor immunity and immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302745

Induction of bystander T cell proliferation by viruses and type I interferon in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302745

Delivery of a stringent dimerizer-regulated gene expression system in a single retroviral vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302745

The TOR pathway: a target for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302745

Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302745

Differential viral induction of distinct interferon-alpha genes by positive feedback through interferon regulatory factor-7

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302745

Nonviral transfer of the gene encoding coagulation factor VIII in patients with severe hemophilia A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302745

Interleukin 12 gene therapy of cancer by peritumoral injection of transduced autologous fibroblasts: outcome of a phase I study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302745

Interferon-beta gene therapy inhibits tumor formation and causes regression of established tumors in immune-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302745

Regulated delivery of therapeutic proteins after in vivo somatic cell gene transfer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302745

Targeting the molecular target of rapamycin (mTOR).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302745

Long-term regulated expression of growth hormone in mice after intramuscular gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302745

Mammalian target of rapamycin inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302745

Rapamycin induces tumor-specific thrombosis via tissue factor in the presence of VEGF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302745

Microvascular injury in pathogenesis of interferon-induced necrosis of subcutaneous tumors in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302745

Interferon (IFN)-beta gene transfer into TS/A adenocarcinoma cells and comparison with IFN-alpha: differential effects on tumorigenicity and host response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302745

Rapid identification of viable retrovirus-transduced cells using the green fluorescent protein as a marker

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302745

Administration of rabbit anti-asialo GM1 antiserum facilitates the development of human Epstein-Barr virus-induced lymphoproliferations in xenografted C.B-17 scid/scid mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302745

Effects of CD2 locus control region sequences on gene expression by retroviral and lentiviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302745

Immunological and non-immunological influence of H-2Kb gene transfection on the metastatic ability of B16 melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302745

Recruitment of human umbilical vein endothelial cells and human primary fibroblasts into experimental tumors growing in SCID mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302745

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.GT.3302745

1 reference

Dimensions Publication ID

19 September 2017

1040818902

0 references

1 reference